Mike Tillinger

Mike Tillinger, MD has extensive experience in clinical development and medical affairs, holding various senior roles in pharmaceutical companies such as Wave Life Sciences, X4 Pharmaceuticals, Corbus Pharmaceuticals, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Purdue Pharma, sanofi-aventis, Tengion, and Novo Nordisk. Mike has led global programs, developed clinical strategies, managed cross-functional teams, and conducted studies across a range of therapeutic areas including pain management, hemostasis, and regenerative technologies. Their responsibilities have included leading clinical development programs, setting global strategies, managing medical teams, and overseeing various advisory boards.

Mike Tillinger, MD, obtained their medical degree in Medicine from Tel Aviv University in 1993 after completing their studies from 1987 to 1993.